secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moderna, Inc. (MRNA)
CIK:        0001682852
Form:       8-K
Filed at:   2026-09-01T20:37:04+00:00
Accession:  0001193125-26-378505
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moderna closes $3.0B 0% convertible notes due 2032; conversion at $210.58
-------------------------------------------------------------------------

- $3.0B aggregate 0.00% convertible senior notes due 2032; conversion price $210.58 (47.5% premium to $142.77).
- Net proceeds ~$2,957.3M; $328.8M used for capped call transactions, rest for oncology growth and debt repayment.
- Capped calls cap price $392.62/share (175% premium), reducing dilution on conversion.
- Notes convertible into up to 14,246,100 shares initially; max 21,012,600 in limited cases.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682852/000119312526378505/0001193125-26-378505-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682852/000119312526378505/d108896d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-378505

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer